Clinical characteristics of the positive LRRK2 p.G2019S patients do not differ from any other PD cases, coinciding with the phenotype described for LRRK2 p.G2019S carriers in other reports 15,32-34. This evidence concerns the gene LRRK2 and Parkinson disease.